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Eating disorders, such as anorexia nervosa (AN), have a significant genetic component. In the current study, a
genomewide linkage analysis of 192 families with at least one affected relative pair with AN and related eating
disorders, including bulimia nervosa, was performed, resulting in only modest evidence for linkage, with the highest
nonparametric linkage (NPL) score, 1.80, at marker D4S2367 on chromosome 4. Since the reduction of sample
heterogeneity would increase power to detect linkage, we performed linkage analysis in a subset ( ) of familiesnp 37
in which at least two affected relatives had diagnoses of restricting AN, a clinically defined subtype of AN char-
acterized by severe limitation of food intake without the presence of binge-eating or purging behavior. When we
limited the linkage analysis to this clinically more homogeneous subgroup, the highest multipointNPL score observed
was 3.03, at marker D1S3721 on chromosome 1p. The genotyping of additional markers in this region led to a
peak multipoint NPL score of 3.45, thereby providing suggestive evidence for the presence of an AN-susceptibility
locus on chromosome 1p.
Eating disorders—psychiatric disorders characterized
by severe disturbances in eating behavior that typical-
ly have onset during late adolescence and young
adulthood—are divided into three major types: anorex-
ia nervosa (AN), bulimia nervosa (BN), and eating dis-
order not otherwise specified (EDNOS). AN is char-
acterized by obsessive fear of weight gain, severely
restricted eating, and low body weight, and, in women,
AN has the highest mortality among the psychiatric
disorders (Sullivan 1995); AN is divided into two clin-
ical subtypes: restricting anorexia nervosa (RAN) and
binge-eating/purging anorexia nervosa (BPAN). A re-
lated disorder (Hsu et al. 1979; Casper et al. 1980;
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Strober et al. 1982; Bulik et al. 1997), BN, can occur
at any body weight and is characterized by binge-eating
and compensatory weight-loss behaviors. Family stud-
ies have shown significantly increased prevalence of
eating disorders in relatives of probands with AN, com-
pared to relatives of control probands (Gershon et al.
1983; Strober et al. 1985; Hudson et al. 1987; Lilenfeld
et al. 1998), thereby providing evidence for the fami-
liality of eating disorders. Twin studies of AN have
included both clinically derived samples (Garfinkel and
Garner 1982; Holland et al. 1984, 1988) and popu-
lation-based investigations (Wade et al. 2000). In these
studies, concordance rates for MZ twins with AN have
been estimated to be 52%–56%, whereas concordance
rates for DZ twins with AN have been estimated to be
5%–11% (Garfinkel and Garner 1982; Holland et al.
1984, 1988; Wade et al. 2000). These studies strongly
suggest that the familiality observed in family studies
is primarily due to genetic causes.
We undertook a multicenter study with an allele-
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Table 1
Characteristics of Probands Partitioned by AN Subtype
ENTIRE SAMPLE
SAMPLE WITH AN
Subgroup with RAN
or BPAN Subgroup with RAN
Mean  SD age (years) 27.76  9.38 28.82  9.84 26.73  8.84
Gender (% males) 5.6 5.5 5.4
Mean  SD body-mass index (kg/m2):
Current 18.62  2.55 18.87  2.74 18.38  2.33
Minimum (past) 14.27  2.28 14.29  2.17 14.25  2.39
Maximum (past) 21.27  2.88 21.49  3.24 21.07  2.47
No. of families:
With one affected sibling paira 147 92 26
With three or four affected siblingsa 16 15 8
With other affected relative pairsb 29 20 3
Total 192 127 37
NOTE.—The original sample was composed of 196 families (4 of which were not used in the genetic analysis,
as detailed in the note to table 2), each including both a proband with a diagnosis of either the RAN or BPAN
subtype and one or more family members affected with AN, BN, or EDNOS. For the families in the subgroup
with RAN, two or more individuals had a diagnosis of RAN. For the families in the subgroup with AN, two
or more individuals had a diagnosis of AN of either subtype. For both the RAN and AN subgroups, any
additional family members with BPAN, BN, or EDNOS were identified as affected, in this table and subsequent
analyses.
a Families may have had additional affected relatives.
b Families included, for example, cousin-cousin relative pairs, aunt-niece relative pairs, or half sibs.
sharing linkage strategy to identify loci that may con-
tribute to AN. Clinical and diagnostic information on
the sample is summarized in table 1. This sample was
composed of 192 families with at least two affected
relatives, all of which were ascertained through a pro-
band who met DSM-IV criteria (American Psychiatric
Association 1994, pp. 544–545) for 13 years when cri-
terion D, amenorrhea, for AN was waived (because
some subjects were menstruating owing to treatment
with exogenous hormone replacement and because
some subjects were male) and who reported a family
history of eating disorders in a first-degree relative (for
a detailed description of this sample, see Kaye et al.
[2000]). Affected relatives met DSM-IV (American Psy-
chiatric Association 1994, pp. 544–545) criteria for
AN, BN, or EDNOS (Kaye et al. 2000). Full assess-
ments were completed on the proband and affected
relative(s) (for details, see Kaye et al. 2000). Eating-
disorder diagnoses were confirmed by trained raters
with the Structured Interview for Anorexia Nervosa
and Bulimic Syndromes (Fichter et al. 1998). Of the
230 relative pairs, 88.8% were female-female, 10.8%
were female-male, and 0.4% was male-male, consis-
tent with the increased prevalence of eating disorders
in females. Mean  SD age of the probands was
years. More than 98% of the families were27.8 9.4
of European ancestry, with 138 families from North
America, 37 families from Germany, and 21 families
from England. Informed consent was obtained from all
study participants, and all sites received approval from
their local institutional review board.
In the entire sample of families, the only multipoint
NPL score 1.5 was observed at marker D4S2367 on
chromosome 4 (see boldface italic values under the head-
ing “Entire Sample” in table 2). Values from multipoint
LOD analysis that allows for heterogeneity (HLOD),
under both dominant and recessive inheritance are
shown. The estimated a values (i.e., estimates of the
fraction of families showing linkage at that locus) under
dominant inheritance was 22% at this position. Mul-
tipoint NPL scores 11.0 were observed at marker
D4S403 on chromosome 4 (NPL score 1.42; ),Pp .07
at marker D11S1392 on chromosome 11 (NPL score
1.20; ), at marker D13S796 on chromosome 13Pp .11
(NPL score 1.03; ), and at marker D15S657 onPp .15
chromosome 15 (NPL score 1.23; ). This modestPp .11
evidence for linkage could reflect either multiple inter-
acting genes, each with weak to moderate effect, and/or
sample heterogeneity.
The reduction of sample heterogeneity should increase
the likelihood of identification of susceptibility loci for
eating disorders. In this study, all families were ascer-
tained through a proband who met criteria for AN; how-
ever, the criteria for affection status were broader for
affected relatives. With the goal of examining the effect
that reduction of clinical heterogeneity has on the genetic
linkage analysis of this sample, we used additional clin-
ical data to define a subgroup ( ) from the originalnp 37
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Table 2
Summary of Highest Multipoint NPL Scores
CHROMOSOME
(MARKER)
DISTANCE
(cM)
ENTIRE SAMPLE SAMPLE WITH RAN
Multipoint
NPL z (P)
HLOD
Multipoint
NPL z (P)
HLOD
Recessive Dominant Recessive Dominant
1 (D1S3721) 72.37 .84 (.20) .19 .17 3.03 (.001) 2.0 1.5
2 (D2S1391) 186.45 .12 (.45) .00 .08 1.70 (.05) .43 .70
4 (D4S403) 25.97 1.42 (.08) .26 .79 1.82 (.03) .59 1.54
4 (D4S2367) 78.50 1.80 (.03) .23 1.05 2.44 (.008) .65 2.23
5 (D5S1501) 85.25 .24 (.59) .00 .00 1.63 (.05) .02 1.06
8 (D8S264) 4.04 .11 (.45) .00 .03 1.90 (.03) 1.36 .70
9 (D9S922) 80.08 .78 (.22) .09 .21 1.51 (.07) .28 .78
16 (D16S748) 22.19 .78 (.78) .00 .00 1.70 (.05) .55 .34
22 (D22S683) 36.16 .63 (.73) .01 .00 1.50 (.07) .44 .13
NOTE.—A peripheral-blood sample was collected from each proband, affected relative, and participating biological parent, and DNA was extracted
according to standard methods (Lahiri and Nurnberger 1991). The Weber screening set, version 9 (Center for Medical Genetics, Marshfield Medical
Research Foundation), which is a screening panel of 386 fluorescently tagged markers dispersed at a density slightly less than 10 cM, was used for
the genomewide scan. Mean SD marker heterozygosity was 0.77 0.06. Genotype information and reported family structures were compared
for inconsistencies (including paternity relationships, twin status, etc.). DNA from four families yielded genotypes that were inconsistent with the
stated family structure and were excluded from subsequent genetic analysis. Multipoint NPL scores were determined using GENEHUNTER(Kruglyak
et al. 1996). The z score and associated P value for markers with peak NPL scores 1.5 for each sample are indicated in boldface italic. In addition,
peak scores and from multipoint HLOD analysis are shown (Smith 1963), under dominant and recessive models and with penetrance set at 50%
(Vieland et al. 1992; Greenberg et al. 1998; Durner et al. 1999). For these parametric analyses, disease-allele frequency was arbitrarily set at 0.1
for recessive inheritance and .006 for dominant inheritance.
sample of families in which two or more affected indi-
viduals had the RAN subtype (table 1). We focused on
the RAN subtype because of its clinical homogeneity
(Kaye et al. 1984; Herzog et al. 1996), which may rep-
resent a sample with greater genetic homogeneity. The
multipoint linkage analysis in the subgroup of 37 fam-
ilies with RAN identified nine peaks with NPL scores
1.5 (see boldface italic values under the heading “Sam-
ple with RAN” in table 2; fig. 1). Two of these peaks
(at markers D4S403 and D4S2367 on chromosome 4)
were included in the set of five peaks, in the entire sam-
ple, that surpassed an NPL threshold of 1.0. The highest
peak that we observed in the sample with RAN was a
multipoint NPL score of 3.03 at marker D1S3721 on
chromosome 1. Multipoint HLOD scores under domi-
nant and recessive models were 1.5 and 2.0, respectively.
Estimates of the fraction of families linked at this po-
sition (a) were 0.45 under the dominant model and 0.41
under the recessive model. This contrasts with estimated
a values, in the entire sample, of 0.17 (dominant) and
0.18 (recessive) at this locus. Although the sample with
RAN included eight families with three or more siblings,
these families did not disproportionately contribute to
the linkage signal.
In a follow-up exploratory study, we defined a further
subgroup of the entire sample; this subgroup was com-
posed of 127 families in which two or more affected
individuals had AN of either the RAN or BPAN subtype,
and it thus excluded the 65 families with both a proband
with a diagnosis of AN and one or more relatives with
BN or EDNOS. The subgroup with AN is more inclusive
than the subgroup with RAN, since the former is com-
posed of all members of the subgroup with RAN in
addition to all members of the subgroup with BPAN.
Sample characteristics for the subgroup with AN are
shown in table 1. In the subgroup with AN, the NPL
score at marker D1S3721 on chromosome 1 was 1.42,
whereas, in the entire sample, the NPL score was 0.83
(fig. 1). Thus, as the affection model was narrowed, the
peak NPL scores at this location increased. This increase
in evidence for linkage is consistent with there being
decreasing genetic heterogeneity as the phenotype is re-
fined. At the second-highest peak (on chromosome 4 at
marker D4S2367) in the original sample, there was a
more modest increase in NPL score as the affection
model was narrowed (table 2).
To increase the genetic information concerning the
observed peak on chromosome 1, we genotyped three
additional markers (D1S255, D1S1598, and D1S447)
in the families with RAN. Additional markers in this
region resulted in a peak multipoint NPL score of 3.45
( ) at marker D1S3721 in the subgroup withPp .00038
RAN (fig. 2). Multipoint HLOD scores were 1.68 un-
der the dominant model and 2.43 under the recessive
model (fig. 2). Estimated a values were 0.45 under the
dominant model and 0.47 under the recessive model.
In the current study, we looked for susceptibility loci
for eating disorders. This study represents the first ge-
nomewide linkage analysis of eating disorders. To date,
population-based association studies have been the pri-
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Figure 1 Evidence for linkage on chromosome 1 in the subgroup with AN. Multipoint NPL z scores (Kruglyak et al. 1996) are plotted,
as a function of chromosomal position, for the three categories of families defined in table 1: the subgroup with RAN ( families; solidnp 37
line), the subgroup with AN ( families; dashed line), and the entire eating-disorder sample ( families; dotted line).np 127 np 192
Figure 2 Evidence for linkage on chromosome 1p, with addi-
tional markers in the subgroup with RAN. Multipoint NPL scores
(dotted line) were calculated across the indicated interval, as were
multipoint HLOD analyses performed under dominant (solid line) and
recessive (dashed line) models, as detailed in the note to table 2. Across
this interval, markers were D1S552, D1S1622, D1S255, D1S1598,
D1S3721, D1S447, and D1S2134. Positions of markers are indicated.
The highest score was over the position of marker D1S3721.
mary approach to the study of the genetics of eating
disorders. Thus far, these candidate-gene analyses have
demonstrated only modest success in the identification
of genes that may be related to AN susceptibility.
The peak scores that we identified in the entire sample
of affected families may indicate the presence of suscep-
tibility loci at these positions but may also represent false
positives. The absence of higher peaks in this large sam-
ple could be due to a number of potential factors:
1. Although eating disorders are substantially herita-
ble, the genetic susceptibility may be due to a number of
interacting loci of small-to-modest effect. If eating dis-
orders arise from a number of interacting genes, then
susceptibility loci may reflect variants of small effect that
are fairly common in the general population. These var-
iants therefore are difficult to identify by linkage analysis.
2. As discussed above, there may be substantial ge-
netic heterogeneity in eating disorders—a possibility that
is supported by the low a values observed parametric
linkage analysis in the entire sample.
The reduction of sample heterogeneity by narrowing
the affection-status model resulted in a peak NPL score
of 3.03, at marker D1S3721 on chromosome 1, which
increased to 3.45 when additional markers were con-
sidered. Evidence for linkage in the subgroup with RAN
was also seen on chromosomes 2, 4, 5, 8, 9, 16, and
22. The evidence for linkage in the subgroup with RAN
must be tempered by our study design, which included
multiple tests. Therefore, until replicated in an indepen-
dent sample, these results can be taken as only suggestive
linkage.
That a more restrictive phenotype increases NPL scores
and HLODs at marker D1S3721 on chromosome 1 sug-
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gests that there is decreased heterogeneity in the subgroup
with RAN, which is consistent with the clinical presen-
tation of RAN. Decreased heterogeneity is also supported
by the higher a values observed in the sample with RAN,
compared to both the sample with AN and the entire
sample. To evaluate whether the evidence for linkage at
marker D1S3721 was derived primarily from the sub-
group with RAN, we performed linkage analysis in the
subset of all families except the 37 families with RAN
( ). By Morton’s predivided sample test, thesenp 155
comparisons provided significant evidence for heteroge-
neity, for both the peak NPL score and HLOD (with
, , and and ,2 2x p 10.13 dfp 1 Pp .0015 x p 8.43
, and , respectively), and support ge-dfp 1 Pp .0037
netic heterogeneity in eating disorders (Morton 1956).
Interestingly, !25% of relative-pair families with RAN
had additional family members in whom other eating dis-
orders had been diagnosed. This suggests that the genetic
vulnerability in these families may lead to manifestation
of eating disorders beyond RAN. In summary, our data
support the presence, on chromosome 1, of a gene for
AN and further suggest that the use of restrictive diag-
noses can decrease heterogeneity and thereby facilitate the
identification of such genes.
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